Medicare coverage and the use of androgen deprivation therapy
Posted Sep 28 2008 7:03pm
Some readers may be interested in an article in today’s Washington Post that asks whether Medicare coverage decisions in 2004 may have impacted the types of hormonal therapy offered to prostate cancer patients. It’s not a big deal, but it does offer some insight into the economics of prostate cancer coverage in the USA.
Some readers may be interested in an article in today’s Washington Post that asks whether Medicare coverage decisions in 2004 may have impacted the types of hormonal therapy offered to prostate cancer patients. It’s not a big deal, but it does offer some insight into the economics of prostate cancer coverage in the USA.
Filed under: Living with Prostate Cancer, Treatment